IL1B and mastitis: Notably, CB treatment in MAC-T cells and mouse mastitis models markedly reduced the expression of IL-1β, TNF-α, and NLRP3, indicating potent anti-inflammatory effects similar to those observed with other natural compounds such as allicin and lentinan [29,30].